Literature DB >> 10191270

Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B.

M Palmblad1, J Johansson, B Robertson, T Curstedt.   

Abstract

Natural surfactant preparations containing phospholipids and the hydrophobic surfactant proteins B and C (SP-B and SP-C) are effective in the treatment of respiratory distress syndrome in premature infants. The limited supply, and the risk of infectious agents and immunological reactions have promoted the evaluation of synthetic peptides in surfactant preparations. However, the folding of synthetic SP-C into an alpha-helix is inefficient and alpha-helical SP-C analogues with Val-->Leu substitutions form oligomers. In order to circumvent these problems we have synthesized an SP-C analogue, named SP-C(LKS), which differs from SP-C mainly by the exchange of most of the Val residues in positions 16-28 with Leu residues to promote an alpha-helical conformation, and by the introduction of Lys residues at positions 17, 22 and 27 in order to locate positive charges around the helical circumference and thereby avoid self polymerization. CD spectroscopy showed a spectrum typical for alpha-helical peptides and SDS/PAGE disclosed a single band. The biophysical activity of artificial surfactant preparations containing SP-C(LKS) and phospholipids, with and without native SP-B, was measured using a Wilhelmy balance and a pulsating bubble surfactometer. SP-C(LKS) (3%, w/w) in a mixture of 1, 2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)/phosphatidylglycerol/palmitic acid (68:22:9, by wt.) suspended in 150 mM NaCl, showed rapid spreading at the air-liquid interface and produced a surface tension of <1 mN/m at minimum bubble size (gammamin) and 42 mN/m at maximum bubble size (gammamax) in the pulsating bubble surfactometer. The addition of 2% (w/w) SP-B to the preparation reduced the maximum surface tension to 33-35 mN/m, i.e. both gammamin and gammamax values were similar to those of natural surfactant preparations. Optimal in vitro characteristics were also obtained from a preparation containing SP-C(LKS), SP-B, DPPC and phosphatidylglycerol, i.e. when palmitic acid was omitted from the lipid mixture. SP-B containing surfactant preparations made up in Hepes buffer at pH 6.9, instead of in 150 mM NaCl, had similar biophysical activity provided that palmitic acid was omitted, but decreased activity in the presence of palmitic acid.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191270      PMCID: PMC1220168     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Surfactant protein B: disulfide bridges, structural properties, and kringle similarities.

Authors:  J Johansson; T Curstedt; H Jörnvall
Journal:  Biochemistry       Date:  1991-07-16       Impact factor: 3.162

Review 2.  Chemical synthesis of peptides and proteins.

Authors:  S B Kent
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

3.  Hydrophobic 3.7 kDa surfactant polypeptide: structural characterization of the human and bovine forms.

Authors:  J Johansson; H Jörnvall; A Eklund; N Christensen; B Robertson; T Curstedt
Journal:  FEBS Lett       Date:  1988-05-09       Impact factor: 4.124

4.  Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups.

Authors:  T Curstedt; J Johansson; P Persson; A Eklund; B Robertson; B Löwenadler; H Jörnvall
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

5.  Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.

Authors:  C J Barrow; A Yasuda; P T Kenny; M G Zagorski
Journal:  J Mol Biol       Date:  1992-06-20       Impact factor: 5.469

6.  The NMR structure of the pulmonary surfactant-associated polypeptide SP-C in an apolar solvent contains a valyl-rich alpha-helix.

Authors:  J Johansson; T Szyperski; T Curstedt; K Wüthrich
Journal:  Biochemistry       Date:  1994-05-17       Impact factor: 3.162

7.  Synthetic peptide-containing surfactants--evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution.

Authors:  G Nilsson; M Gustafsson; G Vandenbussche; E Veldhuizen; W J Griffiths; J Sjövall; H P Haagsman; J M Ruysschaert; B Robertson; T Curstedt; J Johansson
Journal:  Eur J Biochem       Date:  1998-07-01

8.  Pulmonary surfactant protein B (SP-B): structure-function relationships.

Authors:  C G Cochrane; S D Revak
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

9.  Structure and orientation of the surfactant-associated protein C in a lipid bilayer.

Authors:  G Vandenbussche; A Clercx; T Curstedt; J Johansson; H Jörnvall; J M Ruysschaert
Journal:  Eur J Biochem       Date:  1992-01-15

10.  Development of synthetic lung surfactants.

Authors:  Y Tanaka; T Takei; T Aiba; K Masuda; A Kiuchi; T Fujiwara
Journal:  J Lipid Res       Date:  1986-05       Impact factor: 5.922

View more
  5 in total

1.  Combined and independent action of proteins SP-B and SP-C in the surface behavior and mechanical stability of pulmonary surfactant films.

Authors:  David Schürch; Olga L Ospina; Antonio Cruz; Jesús Pérez-Gil
Journal:  Biophys J       Date:  2010-11-17       Impact factor: 4.033

2.  The role of surfactant proteins in DPPC enrichment of surface films.

Authors:  E J Veldhuizen; J J Batenburg; L M van Golde; H P Haagsman
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

3.  The N-terminal segment of pulmonary surfactant lipopeptide SP-C has intrinsic propensity to interact with and perturb phospholipid bilayers.

Authors:  Ines Plasencia; Luis Rivas; Kevin M W Keough; Derek Marsh; Jesús Pérez-Gil
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

4.  Biomimicry of surfactant protein C.

Authors:  Nathan J Brown; Jan Johansson; Annelise E Barron
Journal:  Acc Chem Res       Date:  2008-10-04       Impact factor: 22.384

5.  Can apneic oxygen insufflation become a novel lung protective ventilation strategy? A randomized, controlled, blinded, single center clinical trial.

Authors:  Yongtao Gao; Zhi Wang; Feng Jiang; Jie Gao; Yujia Li; Siyuan Liu
Journal:  BMC Anesthesiol       Date:  2018-12-11       Impact factor: 2.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.